Search

everythinglearnresearchcommunity

for

Search:↓

The herbal combination of saw palmetto and stinging nettle reduces nighttime urination in men with urinary issues.

These medications for BPH have known risks and may have new side effects.

These medications for BPH have known risks and may have new side effects.

Big chain pharmacies in Pennsylvania charge significantly more for generic BPH medications than independent pharmacies, but independent pharmacies have more regional price variation.

Plant-based treatments may help reduce BPH symptoms, but more research is needed.

Methylation of the 5-AR2 gene may cause resistance to Finasteride in BPH patients.

Methylation in specific gene region causes finasteride resistance in some BPH patients.

WS PRO 160 I 120 mg effectively treats urinary symptoms from BPH with good safety and tolerability.

Genetic variations may affect how well finasteride works for BPH patients.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

Combination therapy is more effective for prostate volumes over 60 ml.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

5-alpha reductase inhibitors slightly reduce urinary symptoms and may lower surgery and acute retention risks in men.

Taking 1mg of finasteride daily for hair loss can lower PSA levels by 40-50%, so to keep PSA effective as a cancer screening tool, the PSA value should be doubled during treatment.

SRD5A2 methylation in blood can predict how well someone will respond to finasteride treatment.

COVID-19 worsens urinary symptoms in men with benign prostatic hyperplasia, requiring careful treatment management.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

Certain drugs that block specific enzymes can help treat prostate diseases.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Doxazosin and finasteride negatively affect sexual function in men with BPH.

A new compound that could treat various androgen-related conditions was created and analyzed.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.